Immune Globulin Intravenous Injection Clinical Trials

• Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
  ClinicalTrials.gov Identifier: NCT00004422 - Active, not recruiting
  Pertussis; Whooping Cough
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Safety and Behavior of S. aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients with S. aureus Bacteremia and Continuing Fever
  ClinicalTrials.gov Identifier: NCT00063089 - Completed
  Staphylococcal Infections
  
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
  ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00157079 - Completed
  Primary Immunodeficiency Disorders; Immune Thrombocytopenic Purpura (ITP); Kawasaki syndrome
  
• Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients with Subacute Proximal Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00004407 - Active, not recruiting
  Diabetic Neuropathies
  
• Efficacy of High-Dose Intravenous Immune Globulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
  ClinicalTrials.gov Identifier: NCT00288600 - Recruiting
  Hyperbilirubinemia; Erythroblastosis, Fetal
  
• Randomized Study of Intravenous Immunoglobulin in Patients with Mild or Moderate Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00004682 - Active, not recruiting
  Myasthenia Gravis
  
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00162006 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Safety Study of an Intravenous Staphylococcus aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
  ClinicalTrials.gov Identifier: NCT00066989 - Completed
  Staphylococcal Infections
  
• Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients with Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
  ClinicalTrials.gov Identifier: NCT00161993 - Completed
  Hypogammaglobulinemia; Agammaglobulinemia; Primary immunodeficiency (PID)
  
• Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00473824 - Recruiting
  Hepatitis C Virus; Liver Transplantation
  
• Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
  ClinicalTrials.gov Identifier: NCT00195637 - Active, not recruiting
  Hereditary Inclusion Body Myopathy
  
• Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
  ClinicalTrials.gov Identifier: NCT00220727 - Completed
  Purpura, Thrombocytopenic
  
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
  ClinicalTrials.gov Identifier: NCT00000720 - Completed
  HIV Infections
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00004772 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004747 - Completed
  Cystic Fibrosis; Bacterial Infections
  
• Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00220805 - Completed
  Macular Degeneration
  
• Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00306033 - Completed
  Myasthenia Gravis
  
• An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients with End-Stage Renal Disease Who are Highly Sensitized to Transplant Antigens
  ClinicalTrials.gov Identifier: NCT00000935 - Completed
  End-Stage Renal Disease; Kidney Transplantation
  
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
  ClinicalTrials.gov Identifier: NCT00220766 - Completed
  Immunologic Deficiency Syndrome; Agammaglobulinemia; Severe Combined Immunodeficiency; Wiskott-Aldrich Syndrome; Common Variable Immunodeficiency
  
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00220740 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00542997 - Recruiting
  Common Variable Immunodeficiency; X-Linked Agammaglobulinemia
  
• Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
  
• Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
  ClinicalTrials.gov Identifier: NCT00547365 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00017550 - Active, not recruiting
  Refractory Anemia; refractory anemia with excess blasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes
  
• Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
  ClinicalTrials.gov Identifier: NCT00031291 - Completed
  Anthrax
  
• Safety Study of Anthrax Immune Globulin Derived From Human Serum
  ClinicalTrials.gov Identifier: NCT00448253 - Recruiting
  Symptoms of Inhalational Anthrax
  
• Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
  ClinicalTrials.gov Identifier: NCT00090194 - Completed
  Kidney Failure, Chronic
  
• Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
  ClinicalTrials.gov Identifier: NCT00172302 - Not yet recruiting
  Kidney Failure, Chronic
  
• Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004208 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00001999 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00220779 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Development of Immune Globulin Treatment for Avian Flu
  ClinicalTrials.gov Identifier: NCT00383071 - Recruiting
  Infectious Diseases; Influenza; Avian Flu
  
• Improving Hepatitis C Treatment in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00148031 - Recruiting
  Hepatitis C; Intravenous Drug Abuse; Liver Diseases; Drug Abuse; Alcoholism
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
  ClinicalTrials.gov Identifier: NCT00004286 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• A Dose Escalation Trial of the Safety and Pharmacokinetics of a Single Intravenous Injection of I5NP in Patients Undergoing Major Cardiovascular Surgery
  ClinicalTrials.gov Identifier: NCT00554359 - Recruiting
  Acute Kidney Injury; Acute Renal Failure
  
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00005937 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
  ClinicalTrials.gov Identifier: NCT00000580 - Completed
  Hepatitis B; Hepatitis, Viral, Human; Liver Diseases
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women with Platinum-Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102622 - Active, not recruiting
  Ovarian Cancer
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Study of Immune Ablation With High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed By Autologous Peripheral Blood Stem Cell Rescue in Patients With Severe Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00014703 - No longer recruiting
  Crohn's Disease
  
• Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00016458 - Active, not recruiting
  Systemic Sclerosis
  
• A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00244374 - Recruiting
  Adherence; Community Outreach; HIV Risk Behaviors; Hepatitis A Vaccines; Hepatitis B Vaccines; Hepatitis C; Needle-Exchange Programs; Substance Abuse, Intravenous
  
• Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion
  ClinicalTrials.gov Identifier: NCT00146926 - Active, not recruiting
  Induction of total Intravenous general anesthesia
  
• Study of Human Botulism Immunoglobulin in Infants With Botulism
  ClinicalTrials.gov Identifier: NCT00004401 - Recruiting
  Infant Botulism; Botulism
  
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
  ClinicalTrials.gov Identifier: NCT00230035 - Recruiting
  Systemic Lupus Erythematosus
  
• Biological Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005853 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
  ClinicalTrials.gov Identifier: NCT00113191 - Completed
  Nosocomial Infections; Sepsis; Staphylococcal Infections; Candidemia
  
• Comparison of Low-Dose Epidural With Intravenous Narcotic Versus Intravenous Narcotic Alone
  ClinicalTrials.gov Identifier: NCT00287326 - Recruiting
  Pain
  
• Phase I Safety Study of anti-HIV Immune Serum Globulin (Human)
  ClinicalTrials.gov Identifier: NCT00002036 - Completed
  HIV Infections
  
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
  ClinicalTrials.gov Identifier: NCT00006630 - Terminated
  Healthy; Communicable Diseases
  
• Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00017641 - Active, not recruiting
  Systemic Lupus Erythematosus
  
• Phase III Randomized Study of Cyclophosphamide with or without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients with Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00004474 - Active, not recruiting
  Aplastic Anemia
  
• Treating Severe Chronic Epstein-Barr Virus (EBV) Infection with EBV Specific Cytotoxic T Lymphocytes (CTLs)
  ClinicalTrials.gov Identifier: NCT00058591 - Active, not recruiting
  Epstein-Barr Virus Infections
  
• The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
  ClinicalTrials.gov Identifier: NCT00002264 - Completed
  Cryptosporidiosis; HIV Infections
  
• Allogeneic Peripheral Stem Cell Transplantation After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast
  ClinicalTrials.gov Identifier: NCT00074269 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Kidney Transplants in People with HIV Infection
  ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
  HIV Infections; End-Stage Renal Disease
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099203 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00016419 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
  ClinicalTrials.gov Identifier: NCT00168038 - Completed
  Immune Thrombocytopenic Purpura
  
• The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
  ClinicalTrials.gov Identifier: NCT00000961 - Terminated
  HIV Infections
  
• Cocaine-Metyrapone Interaction Study - 1
  ClinicalTrials.gov Identifier: NCT00033098 - Active, not recruiting
  Cocaine-Related Disorders; Infusions, Intravenous
  
• Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
  ClinicalTrials.gov Identifier: NCT00462020 - Recruiting
  Perforated Appendicitis
  
• Intravenous micronutrient therapy (IVMT) for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00067405 - Active, not recruiting
  Fibromyalgia
  
• Yellow Fever Virus Vaccine and Immune Globulin Study
  ClinicalTrials.gov Identifier: NCT00254826 - Recruiting
  Viremia; Yellow Fever Virus Vaccine
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00003913 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Effects of Epinephrine and Intravenous (I.V.) Needle On Cardiopulmonary Resuscitation (CPR) Outcome
  ClinicalTrials.gov Identifier: NCT00121524 - Recruiting
  Cardiac Arrest
  
• Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions with Cocaine - 1
  ClinicalTrials.gov Identifier: NCT00033046 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule; Infusions, Intravenous
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00055653 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Drug Interaction Study with NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
  ClinicalTrials.gov Identifier: NCT00032916 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule; Infusions, Intravenous
  
• Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years
  ClinicalTrials.gov Identifier: NCT00232895 - Completed
  ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00068523 - Active, not recruiting
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Jet Injection of 1% Buffered Lidocaine Versus Topical ELA-Max for Anesthesia Prior to Intravenous (IV) Catheterization in Children
  ClinicalTrials.gov Identifier: NCT00444756 - Completed
  Pain
  
• High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
  ClinicalTrials.gov Identifier: NCT00080977 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Phase I Study of High-Dose Cyclophosphamide, Anti-Thymocyte Globulin, and Total Body Irradiation With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00017615 - Recruiting
  Rheumatoid Arthritis; Juvenile Rheumatoid Arthritis
  
• Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
  ClinicalTrials.gov Identifier: NCT00058604 - Recruiting
  Epstein-Barr Virus Infections; Lymphoproliferative Disorders
  
• Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00028730 - Active, not recruiting
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ...
  
• Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
  ClinicalTrials.gov Identifier: NCT00265278 - Active, not recruiting
  Amphetamine-Related Disorders
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
  ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
  Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
  
• Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage
  ClinicalTrials.gov Identifier: NCT00124150 - Recruiting
  Subarachnoid Hemorrhage
  
• Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436761 - Active, not recruiting
  Unspecified Childhood Solid Tumor, Protocol Specific
  
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301951 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00054340 - Active, not recruiting
  acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003839 - Recruiting
  Cancer
  
• Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00217386 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
  ClinicalTrials.gov Identifier: NCT00084695 - Recruiting
  Fanconi's Anemia; Cancer
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Safety/Efficacy of Induction Agents with Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00113269 - Active, not recruiting
  Kidney Transplantation
  
• Combination Therapy of Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001964 - Active, not recruiting
  Aplastic Anemia
  
• Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
  ClinicalTrials.gov Identifier: NCT00322556 - Active, not recruiting
  Agammaglobulinemia; IgG Deficiency; Common Variable Immunodeficiency
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Intravenous Immunoglobulin (IVIG) in Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00115778 - Recruiting
  Hypogammaglobulinemia; Lung Transplantation